|
107
|
355
|
6ghkA |
Human parp1 (artd1) - catalytic domain in complex with inhibitor me0527 |
|
104
|
348
|
6i8tA |
The catalytic fragment of poly(adp-ribose) polymerase complexed with an isoindolinone inhibitor |
|
45
|
162
|
6a84A |
Tankyrase-2 in complex with compound 15d |
|
46
|
162
|
5zqpA |
Tankyrase-2 in complex with compound 12 |
|
1
|
47
|
6a84B |
Tankyrase-2 in complex with compound 15d |
|
1
|
46
|
5zqrB |
Tankyrase-2 in complex with compound 40c |
|
1
|
47
|
5zqoB |
Tankyrase-2 in complex with compound 1a |
|
69
|
182
|
5qhvA |
Pandda analysis group deposition -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000299a |
|
69
|
182
|
5qi5A |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000633a |
|
68
|
182
|
5qhzA |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000385a |
|
45
|
162
|
5zqqA |
Tankyrase-2 in complex with compound 52 |
|
67
|
182
|
5qhuA |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmsoa000341b |
|
44
|
162
|
5zqrA |
Tankyrase-2 in complex with compound 40c |
|
45
|
162
|
5zqoA |
Tankyrase-2 in complex with compound 1a |
|
68
|
182
|
5qi3A |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000475a |
|
67
|
182
|
5qhxA |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000278a |
|
70
|
182
|
5qi8A |
Pandda analysis group deposition -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000605a |
|
69
|
182
|
5qi0A |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000352a |
|
68
|
182
|
5qi4A |
Pandda analysis group deposition -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000466a |
|
66
|
182
|
5qi2A |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000110a |
|
1
|
47
|
5zqpB |
Tankyrase-2 in complex with compound 12 |
|
70
|
182
|
5qhyA |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000462a |
|
67
|
182
|
5qiaA |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000242a |
|
67
|
182
|
5qi1A |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000474a |
|
69
|
182
|
5qhtA |
Pandda analysis group deposition -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000065a |
|
68
|
182
|
5qhwA |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000347a |
|
1
|
47
|
5zqqB |
Tankyrase-2 in complex with compound 52 |
|
67
|
182
|
5qi7A |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000506a |
|
31
|
116
|
6f5fA |
Structure of artd2/parp2 wgr domain bound to double strand dna with 5 nucleotide overhang and 5'phosphate |
|
49
|
191
|
5lxpA |
Human parp14 (artd8), catalytic fragment in complex with inhibitor h5 |
|
51
|
191
|
5lx6A |
Human parp10 (artd10), catalytic fragment in complex with parp inhibitor veliparib |
|
49
|
190
|
5lyhA |
Human parp14 (artd8), catalytic fragment in complex with inhibitor h10 |
|
109
|
350
|
5kppA |
Structure of human parp1 catalytic domain bound to a quinazoline-2,4(1h,3h)-dione inhibitor |
|
17
|
58
|
5kniA |
Crystal structure of the wild-type sam domain of human tankyrase-1 |
|
107
|
352
|
5kpoA |
Structure of human parp1 catalytic domain bound to a quinazoline-2,4(1h,3h)-dione inhibitor |
|
20
|
63
|
5jtiA |
Crystal structure of the human tankyrase 1 (tnks) sam domain (d1055r), crystal form 2 |
|
22
|
64
|
5jrtA |
Crystal structure of the human tankyrase 2 (tnks2) sam domain (dh902/924re) |
|
18
|
60
|
5ju5A |
Crystal structure of the human tankyrase 1 (tnks) sam domain (d1055r), crystal form 1 |
|
33
|
159
|
5fpfA |
Crystal structure of human tankyrase 2 in complex with ta-91 |
|
46
|
162
|
5adrA |
Crystal structure of human tankyrase 2 in complex with od38 |
|
46
|
162
|
5adsA |
Crystal structure of human tankyrase 2 in complex with od39 |
|
45
|
162
|
5adqA |
Crystal structure of human tankyrase 2 in complex with jw55 |
|
52
|
189
|
6g0wA |
Human parp14 (artd8), catalytic fragment in complex with inhibitor mcd72 |
|
52
|
197
|
6ek3A |
Parp15 catalytic domain mutant (y598l) in complex with oul35 |
|
123
|
320
|
6cf6A |
Rnf146 tbm-tankyrase arc2-3 complex |
|
63
|
246
|
6bhvA |
Human parp-1 bound to nad+ analog benzamide adenine dinucleotide (bad) |
|
101
|
349
|
5xsrA |
Novel orally efficacious inhibitors complexed with parp1 |
|
114
|
352
|
5wrzA |
Structure of human parp1 catalytic domain bound to a phthalazinone inhibitor |
|
114
|
352
|
5wryA |
Structure of human parp1 catalytic domain bound to a quinazoline-2,4(1h,3h)-dione inhibitor |
|
107
|
352
|
5ws0A |
Structure of human parp1 catalytic domain bound to a benzoimidazole inhibitor |
